Effects of cefamandole on hemostasis in patients undergoing hip replacement with heparin prophylaxis.

G Agnelli, R Guerciolini, F Boldrini, A Tonzani, P Della Torre, G G Nenci, A Del Favero
{"title":"Effects of cefamandole on hemostasis in patients undergoing hip replacement with heparin prophylaxis.","authors":"G Agnelli,&nbsp;R Guerciolini,&nbsp;F Boldrini,&nbsp;A Tonzani,&nbsp;P Della Torre,&nbsp;G G Nenci,&nbsp;A Del Favero","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The aim of this study was to compare the effects of the prophylactic use of cefamandole versus oxacillin plus gentamicin on hemostasis in patients undergoing hip replacement with heparin prophylaxis. Twenty-four patients with a normal hemostatic profile were randomly allocated to receive either cefamandole or oxacillin plus gentamicin. All the patients received calcium heparin. Platelet count, bleeding time, prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin clotting time (TCT), fibrinogen and serum FDP were assessed before treatment and every day of antibiotic administration. Surgical bleeding was assessed using a four-grade score system. Platelet count, bleeding time, fibrinogen and serum FDP did not show any change with both treatments. PT, aPTT and TCT showed a similar and mild prolongation in the two groups of patients. No difference in the surgical bleeding was observed between the two groups. We conclude that a short-term prophylaxis with cefamandole is a safe regimen in patients undergoing hip replacement with heparin prophylaxis.</p>","PeriodicalId":9733,"journal":{"name":"Chemioterapia : international journal of the Mediterranean Society of Chemotherapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1988-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemioterapia : international journal of the Mediterranean Society of Chemotherapy","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The aim of this study was to compare the effects of the prophylactic use of cefamandole versus oxacillin plus gentamicin on hemostasis in patients undergoing hip replacement with heparin prophylaxis. Twenty-four patients with a normal hemostatic profile were randomly allocated to receive either cefamandole or oxacillin plus gentamicin. All the patients received calcium heparin. Platelet count, bleeding time, prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin clotting time (TCT), fibrinogen and serum FDP were assessed before treatment and every day of antibiotic administration. Surgical bleeding was assessed using a four-grade score system. Platelet count, bleeding time, fibrinogen and serum FDP did not show any change with both treatments. PT, aPTT and TCT showed a similar and mild prolongation in the two groups of patients. No difference in the surgical bleeding was observed between the two groups. We conclude that a short-term prophylaxis with cefamandole is a safe regimen in patients undergoing hip replacement with heparin prophylaxis.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
头孢曼铎对肝素预防髋关节置换术患者止血的影响。
本研究的目的是比较预防性使用头孢门多与奥西林加庆大霉素对肝素预防髋关节置换术患者止血的影响。24例止血情况正常的患者被随机分配接受头孢门多尔或奥西林加庆大霉素治疗。所有患者均接受肝素钙治疗。在治疗前及给药后每日评估血小板计数、出血时间、凝血酶原时间(PT)、活化部分凝血活酶时间(aPTT)、凝血酶凝固时间(TCT)、纤维蛋白原及血清FDP。手术出血采用四级评分系统进行评估。两组患者血小板计数、出血时间、纤维蛋白原和血清FDP均无明显变化。两组患者的PT、aPTT和TCT均有相似的轻度延长。两组手术出血无明显差异。我们的结论是,短期预防头孢门多尔是一种安全的方案,患者接受髋关节置换术与肝素预防。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The natural history of hepatitis B virus infection. The effectiveness of chemotherapy in localized malignant fibrous histiocytoma (MFH) of bone: the Rizzoli Institute experience with 66 patients treated with surgery alone or surgery + adjuvant or neoadjuvant chemotherapy. Perspectives for the chemotherapy of AIDS. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial. Interferon treatment of anti-HBe positive and HBV DNA positive chronic hepatitis B.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1